Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × tivozanib × Clear all

NCT01478594 2015-07-08

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

Phase 2 Completed

265 enrolled 34 charts

Gastrointestinal

Colorectal Neoplasms